Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting
暂无分享,去创建一个
Alexander Radbruch | Karl Kiening | Sina Burth | Martin Bendszus | Heinz-Peter Schlemmer | Felix Sahm | Pascal J. Kieslich | Philipp Kickingereder | Andreas Unterberg | Wolfgang Wick | Jan-Oliver Neumann | H. Schlemmer | K. Kiening | A. Unterberg | W. Wick | C. Jungk | P. Kickingereder | A. Radbruch | M. Bendszus | J. Neumann | F. Sahm | Sina Burth | Oliver Eidel | Christine Jungk | Oliver Eidel
[1] S. Cha,et al. Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma , 2010, American Journal of Neuroradiology.
[2] Christopher Nimsky,et al. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. , 2006, Radiology.
[3] A. Brodbelt,et al. Cellularity and apparent diffusion coefficient in oligodendroglial tumours characterized by genotype , 2010, Journal of Neuro-Oncology.
[4] A. Lagares,et al. A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas , 2014, American Journal of Neuroradiology.
[5] P. LaViolette,et al. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity , 2010, Journal of magnetic resonance imaging : JMRI.
[6] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[7] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[8] Mitchel S Berger,et al. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. , 2012, Neuro-oncology.
[9] [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma]. , 2005, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[10] Aidos Doskaliyev,et al. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. , 2012, European journal of radiology.
[11] T. Hirai,et al. Magnetic resonance imaging of pilocytic astrocytomas: usefulness of the minimum apparent diffusion coefficient (adc) value for differentiation from high-grade gliomas , 2008, Acta radiologica.
[12] R C McKinstry,et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. , 2001, AJR. American journal of roentgenology.
[13] James M Provenzale,et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.
[14] Alexander Radbruch,et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging. , 2014, Radiology.
[15] Marc Lartaud,et al. Analyzing huge pathology images with open source software , 2013, Diagnostic Pathology.
[16] P. LaViolette,et al. Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma. , 2014, Neuro-oncology.
[17] Inas S. Khayal,et al. Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM , 2009, Journal of Neuro-Oncology.
[18] J.,et al. The New England Journal of Medicine , 2012 .
[19] S. Higano,et al. Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas , 2009, Neurological research.
[20] Usha Sinha,et al. Relationships Between Choline Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficient and Quantitative Histopathology in Human Glioma , 2000, Journal of Neuro-Oncology.
[21] S. Higano,et al. Minimum apparent diffusion coefficient for the differential diagnosis of ganglioglioma , 2009, Neurological research.
[22] C. Decaestecker,et al. Apparent Diffusion Coefficient and Cerebral Blood Volume in Brain Gliomas: Relation to Tumor Cell Density and Tumor Microvessel Density Based on Stereotactic Biopsies , 2008, American Journal of Neuroradiology.
[23] Ying Lu,et al. Survival analysis in patients with glioblastoma multiforme: Predictive value of choline‐to‐n‐acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume , 2004, Journal of magnetic resonance imaging : JMRI.
[24] S. Ng,et al. Primary Cerebral Lymphoma and Glioblastoma Multiforme: Differences in Diffusion Characteristics Evaluated with Diffusion Tensor Imaging , 2008, American Journal of Neuroradiology.
[25] Toshinori Hirai,et al. Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.
[26] Yutaka Imai,et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer , 2008, Radiation Medicine.
[27] T. Hirai,et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. , 2007, Radiology.
[28] K. Kono,et al. The role of diffusion-weighted imaging in patients with brain tumors. , 2001, AJNR. American journal of neuroradiology.
[29] T. Hirai,et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. , 2006, AJNR. American journal of neuroradiology.
[30] P. Loehrer. Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma , 2006 .
[31] Lihua Chen,et al. The Correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis , 2013, PloS one.
[32] Walter Stummer,et al. The importance of surgical resection in malignant glioma , 2009, Current opinion in neurology.
[33] D. Yousem,et al. ADC values and prognosis of malignant astrocytomas: does lower ADC predict a worse prognosis independent of grade of tumor?--a meta-analysis. , 2013, AJR. American journal of roentgenology.
[34] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.